search: results update below


browse funds: selections are stored



recently rated:

Rated by 7
2.5

top rated funds:

Rated by 12
4.1

Rated by 11
4.0
 

Rated by 15
4.0

Rated by 41
3.9

Rated by 11
3.8

Rated by 44
3.8

Rated by 106
3.8

Rated by 32
3.8

Rated by 32
3.8

Rated by 64
3.7

Rated by 23
3.7

Rated by 27
3.7

Rated by 11
3.6

Rated by 18
3.6

Rated by 10
3.6
 

Rated by 63
3.6

Rated by 21
3.5

Rated by 12
3.5
 

Rated by 30
3.5

Rated by 28
3.4

Rated by 14
3.4
 

Rated by 49
3.4
 

Rated by 16
3.4
 

Rated by 10
3.4

Rated by 13
3.4

Rated by 16
3.4

Rated by 60
3.4

Rated by 17
3.4

Rated by 18
3.3

Rated by 39
3.3
 

Please take a moment and make a financial contribution to TheFunded. If we have helped you, help us with resources to further grow the both the site and our entrepreneur training program, The Founder Institute.

Member Post

TheFunded.com is an online community of over 20,000 CEOs, Founders and entrepreneurs to discuss fundraising, rate and review angel investors and venture capitalists, and discuss strategies to grow a startup business. Enjoy the site, and be sure to join us at our Founder Showcase events to meet the community.

Sign-up for Membership

0
Agree
4
Disagree

Tif Honest and Upfront

Fund: Accuitive Medical Ventures

Posted by Anonymous on 2010-04-09

PUBLIC:

I was approached by The Innovation Factory, the incubator arm of Accuitive Medical Ventures. They were very upfront and honest about what they do:

- Take your IP and put it into a Newco
- Take between 60-90% of the equity in the Newco and give you the rest
- Then raise capital for the Newco from established VCs

Their goal is to generate human proof of concept or some other key technical milestone as quickly and inexpensively as they can. They did not hide any of this or try to trick me into signing away our stuff. Very upfront.

For an idea or a company just getting off the ground, like a university professor with a new idea for a medical device, this could be a great way to get involved with highly experienced professionals. Their capital raising connections are excellent and they are trying to expand beyond just Versant and SV as their main VCs.

The deal wasn't for us because we had already raised some seed capital and were beginning to make progress, but for a professor or someone like that with an early stage idea, I would not dismiss it.

If you are worried about control, then you don't get it. For biotechs and medical device companies you lose control as soon as the VCs come in anyway.

PRIVATE: Members Only